Patent · US Active

Nucleic acids obtained from LAVMAL, a variant African AIDS virus

US7767800B2 · kind B2 · utility

2Cited by
9References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2003
Grant dateAug 3, 2010
Priority date
Expiry dateSep 7, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16051
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A variant of a LAV virus, designated LAVMAL and capable of causing AIDS. The cDNA and antigens of the LAVMAL virus can be used for the diagnosis of AIDS and pre-AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.